Skip to content

Clinical trials

Phase 2 Polycythemia Vera trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polycythemia Vera Phase: Phase 2 Country / region: Germany Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20132
20142
20151
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sierra Oncology LLC - a GSK company2
European Organisation for Research and Treatment of Cancer - EORTC1
Geron Corporation1
Hoffmann-La Roche1
Incyte Corporation1
Italfarmaco1
Kartos Therapeutics, Inc.1
RWTH Aachen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polycythemia Vera9
Thrombocythemia, Essential6
Primary Myelofibrosis5
Myeloproliferative Disorders4
Hematologic Diseases2
Thrombocytosis2
Ataxia Telangiectasia1
Blast Crisis1
Blood Coagulation Disorders1
Blood Platelet Disorders1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.